These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 12903804

  • 1. Immunotherapy in multiple myeloma: current strategies and future prospects.
    Yi Q.
    Expert Rev Vaccines; 2003 Jun; 2(3):391-8. PubMed ID: 12903804
    [Abstract] [Full Text] [Related]

  • 2. Novel immunotherapies.
    Yi Q.
    Cancer J; 2009 Jun; 15(6):502-10. PubMed ID: 20010170
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research.
    Bogen B, Ruffini PA, Corthay A, Fredriksen AB, Frøyland M, Lundin K, Røsjø E, Thompson K, Massaia M.
    Haematologica; 2006 Jul; 91(7):941-8. PubMed ID: 16818282
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Active immunotherapy of multiple myeloma.
    Houet L, Veelken H.
    Eur J Cancer; 2006 Jul; 42(11):1653-60. PubMed ID: 16797966
    [Abstract] [Full Text] [Related]

  • 7. Vaccines for lymphomas: idiotype vaccines and beyond.
    Houot R, Levy R.
    Blood Rev; 2009 May; 23(3):137-42. PubMed ID: 18951668
    [Abstract] [Full Text] [Related]

  • 8. Idiotypic vaccination as therapy for multiple myeloma.
    Kwak LW, Thielemans K, Massaia M.
    Semin Hematol; 1999 Jan; 36(1 Suppl 3):34-7. PubMed ID: 9989488
    [Abstract] [Full Text] [Related]

  • 9. Cellular immunotherapy for multiple myeloma.
    Rosenblatt J, Avigan D.
    Best Pract Res Clin Haematol; 2008 Sep; 21(3):559-77. PubMed ID: 18790455
    [Abstract] [Full Text] [Related]

  • 10. [The preparation of myeloma-specific T cells activated with dendritic cells loaded with nonapeptides derived from mucin protein MUC1 and catalytic subunit of telomerase hTERT].
    Ocadlíková D, Kovárová L, Hájek R, Michálek J.
    Klin Onkol; 2008 Sep; 21(2):59-65. PubMed ID: 19102213
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Peptide-based immunotherapy for multiple myeloma: current approaches.
    Zhou FL, Meng S, Zhang WG, Wei YC, Cao XM, Bai GG, Wang BY.
    Vaccine; 2010 Aug 23; 28(37):5939-46. PubMed ID: 20619381
    [Abstract] [Full Text] [Related]

  • 13. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J, Wang S, Yang J, Xie J, Lin P, Freeman ME, Yi Q.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [Abstract] [Full Text] [Related]

  • 14. Advances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials.
    Chiriva-Internati M, Cobos E, Kast WM.
    Int Rev Immunol; 2007 Dec 15; 26(3-4):197-222. PubMed ID: 17558744
    [Abstract] [Full Text] [Related]

  • 15. Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma.
    Neelapu SS, Munshi NC, Jagannath S, Watson TM, Pennington R, Reynolds C, Barlogie B, Kwak LW.
    Bone Marrow Transplant; 2005 Aug 15; 36(4):315-23. PubMed ID: 15968284
    [Abstract] [Full Text] [Related]

  • 16. Idiotypic vaccination in B-cell malignancies.
    Bianchi A, Massaia M.
    Mol Med Today; 1997 Oct 15; 3(10):435-41. PubMed ID: 9358470
    [Abstract] [Full Text] [Related]

  • 17. Recent advances in multiple myeloma immunotherapy.
    Ruffini PA, Biragyn A, Kwak LW.
    Biomed Pharmacother; 2002 May 15; 56(3):129-32. PubMed ID: 12046683
    [Abstract] [Full Text] [Related]

  • 18. The role of idiotype vaccines in the treatment of human B-cell malignancies.
    Bendandi M.
    Expert Rev Vaccines; 2004 Apr 15; 3(2):163-70. PubMed ID: 15056042
    [Abstract] [Full Text] [Related]

  • 19. Immunotherapy in multiple myeloma--possibility or probability?
    Harrison SJ, Cook G.
    Br J Haematol; 2005 Aug 15; 130(3):344-62. PubMed ID: 16042684
    [Abstract] [Full Text] [Related]

  • 20. Current role of immunotherapy in multiple myeloma.
    Hájek R, Adam Z, Krivanová A, Doubek M, Korístek Z, Vorlícek J.
    Acta Med Austriaca; 1998 Aug 15; 25(3):79-85. PubMed ID: 9816399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.